Healthcare & Life Sciences

Revolver Therapeutics

pre-seed
pre-seed
Stage
1
Investors

About

Revolver Therapeutics is a University of Bath spinout developing and exploring potential drug candidates to treat childhood glioma. The company focuses on discovering and advancing therapeutics for pediatric brain cancer.

Explore Revolver Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.